California State Teachers Retirement System (CalSTRS)
RXRX icon

California State Teachers Retirement System (CalSTRS)’s Recursion Pharmaceuticals RXRX Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.76M Buy
574,637
+224,332
+64% +$867K ﹤0.01% 1588
2025
Q4 		$1.43M Buy
350,305
+18,103
+5% +$89.7K ﹤0.01% 1608
2025
Q3 		$1.62M Buy
332,202
+15
+0% +$79 ﹤0.01% 1526
2025
Q2 		$1.68M Buy
332,187
+102,020
+44% +$501K ﹤0.01% 1456
2025
Q1 		$1.22M Sell
230,167
-1,368
-0.6% -$9.97K ﹤0.01% 1594
2024
Q4 		$1.57M Buy
231,535
+54,449
+31% +$366K ﹤0.01% 1522
2024
Q3 		$1.17M Buy
177,086
+8,064
+5% +$57.8K ﹤0.01% 1697
2024
Q2 		$1.27M Buy
169,022
+14,531
+9% +$127K ﹤0.01% 1637
2024
Q1 		$1.54M Buy
154,491
+4,828
+3% +$53.8K ﹤0.01% 1563
2023
Q4 		$1.48M Buy
149,663
+5,333
+4% +$38K ﹤0.01% 1623
2023
Q3 		$1.1M Sell
144,330
-14,062
-9% -$140K ﹤0.01% 1731
2023
Q2 		$1.18M Buy
158,392
+59,698
+60% +$418K ﹤0.01% 1811
2023
Q1 		$658K Buy
98,694
+1,102
+1% +$8.74K ﹤0.01% 2152
2022
Q4 		$752K Buy
97,592
+1,326
+1% +$13K ﹤0.01% 2097
2022
Q3 		$1.02M Sell
96,266
-2,254
-2% -$22.8K ﹤0.01% 1873
2022
Q2 		$802K Buy
98,520
+14,123
+17% +$94.5K ﹤0.01% 2106
2022
Q1 		$604K Sell
84,397
-11,938
-12% -$127K ﹤0.01% 2317
2021
Q4 		$1.65M Buy
96,335
+81,132
+534% +$1.53M ﹤0.01% 1852
2021
Q3 		$350K Sell
15,203
-13,951
-48% -$395K ﹤0.01% 2562
2021
Q2 		$1.06M Buy
+29,154
New +$863K ﹤0.01% 2175

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s RXRX Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) increased its Recursion Pharmaceuticals (RXRX) stake by 64% in Q1 2026, buying an estimated $867K and bringing the position to 574,637 shares worth $1.76M. The position accounts for ﹤0.01% of the portfolio, ranked #1588.

California State Teachers Retirement System (CalSTRS) first reported a position in RXRX in Q2 2021 and has held it in 20 quarters since. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) held 574,637 shares of Recursion Pharmaceuticals worth $1.76M as of Q1 2026.
  • California State Teachers Retirement System (CalSTRS) bought 224,332 Recursion Pharmaceuticals shares in Q1 2026, an estimated $867K.
  • Recursion Pharmaceuticals made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #1588 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Recursion Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.